Screener
Bioventus BVS Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | June 27, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $20,196 | $10,928 |
| Accrued liabilities | 109,361 | 130,242 |
| Current portion of long-term debt | 18,750 | 15,000 |
| Other current liabilities | 4,144 | 4,210 |
| Total current liabilities | 152,451 | 160,380 |
| Long-term debt, less current portion | 229,702 | 278,951 |
| Deferred income tax liabilities | 568 | 433 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's current debt?
- Bioventus (BVS) reported current debt of $18.75M in Q2 2026.
- How has Bioventus's current debt changed year-over-year?
- Bioventus's current debt decreased by 56.8% year-over-year, from $43.36M to $18.75M.
- What is the long-term trend for Bioventus's current debt?
- Over 5 years (2020 to 2025), Bioventus's current debt has grown at a 0.0% compound annual growth rate (CAGR), from $15M to $15M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Bioventus's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude